Best Promising Companies To Own In Right Now

"India is one of the world's most promising and problematic Internet markets," wrote Brad Stone and Kartikay Mehrotra in a recent�Businessweek article. They're spot on. The combination of very undeveloped Internet and e-commerce infrastructure; adoption of Internet-connected devices in droves; and a massive population of 1 billion people all set the stage for opportunity -- albeit with significant risk. eBay (NASDAQ: EBAY  ) thinks it can buck system, but it may take a while.

The market
About 100 million people in India, or 10% of the population, use the Internet. The market opportunity for companies willing to jump into the country's Internet space, therefore, is a whopping 900 million. But there's no reason to get too excited; much of this market is far from ready to adopt Internet-connected devices. Though wages are on the rise, growing 11% last year,�the average per capita income is still just $106 per month. Furthermore, though 100 million people in India use the Internet, only 10 million of these individuals have access to high-speed Internet. Finally, India doesn't have a national shipping company, severely limiting e-commerce efforts.

Top Heal Care Stocks For 2015: BMC Software Inc. (BMC)

BMC Software, Inc. develops software that provides system and service management solutions for enterprises in the United States and internationally. The company operates in two segments, Enterprise Service Management and Mainframe Service Management. The Enterprise Service Management segment offers service assurance solutions that manage availability and performance management, event management, service impact management, and capacity management; service automation solutions managing provisioning, configuration change, and compliance automation for servers, networks, applications, and databases; service support solutions, which manages service desk, incident management, service request management, problem management, asset management, service level management, change and release management, and identity management; and BMC Atrium that provides shared technologies that unify information and processes from disparate management tools, and assigns priorities to business servic es. It also offers consulting, implementation, integration, IT process design and re-engineering, and educational services related to its software products. The Mainframe Service Management segment provides mainframe data and performance management solutions that ensure the availability and reliability of the business critical data, applications, and systems; and enterprise workload automation solutions comprising CONTROL-M product line, a set of features enabling data centers to automate their complex workloads and critical business processes. The company serves manufacturers, telecommunication companies, educational institutions, retailers, distributors, hospitals, and other industries, as well as channel partners, including resellers, distributors and systems integrators directly. BMC Software, Inc. was founded in 1980 and is headquartered in Houston, Texas.

Advisors' Opinion:

• [By Tom Taulli]

  As with many other hot cloud companies, NOW stock has been a roller coaster lately. But this isn’t an issue for the company�� CEO, Frank Slootman. I met with Slootman recently, and he told me that ServiceNow could be instantly profitable if he dialed down growth. He said that would be a mistake, though, because the market opportunity is massive. His competition is mostly made up of legacy operators like BMC (BMC) and Hewlett-Packard (HPQ).

Best Promising Companies To Own In Right Now: Komatsu Ltd (KMTUY)

Komatsu Ltd. (Komatsu), incorporated in May 13, 1921, is a global company engaged in the manufacturing, development, marketing and sale of a range of industrial-use products and services. The manufacturing operations of Komatsu are conducted primarily at plants located in Japan, the United States, Brazil, the United Kingdom, Germany, Sweden, Italy, Indonesia, China, Thailand and India. Komatsu�� products are primarily sold under the Komatsu brand name and almost all of its sales and service activities are conducted through its sales subsidiaries and independent distributors who primarily sell products to retail dealers in their respective geographic area. Komatsu operates and competes in the six principal markets, such as Japan, the United States, Europe and Commonwealth of Independent States (CIS), China, Asia (excluding Japan and China) and Oceania and the Middle East and Africa. In May, 2009, Komatsu acquired the additional interest in Komatsu Australia Corporate Finance Pty. Ltd.

Construction, Mining and Utility Equipment

The Company offers various types of construction, mining and utility equipment, ranging from super-large machines capable of mining applications to general construction equipment and mini construction equipment for urban use. Komatsu�� range of products in this operating segment also includes a variety of attachments to be used with its products. Komatsu�� principal products include excavating equipment, loading equipment, grading and roadbed preparation equipment, hauling equipment, forestry equipment, tunneling machines, recycling equipment, industrial vehicles, other equipment, engines and components, casting products and logistics.

Industrial Machinery and Others

The Company�� Industrial Machinery and Others segment products are used by a range of businesses and include industrial machinery, such as forging and sheet metal machinery and other services. Komatsu�� principal products include metal forging and stampi! ng presses, sheet metal machines, machine tools, defense systems, temperature-control equipment and others.

The Company competes with Caterpillar Inc., Hitachi Construction Machinery Co., Ltd., Volvo Construction Equipment NV, CNH Global N.V., Hyundai Heavy Industries Co., Ltd., Doosan Infracore Co., Ltd. and Toyota Motor Corporation.

Advisors' Opinion:

• [By Dan Carroll]

  That doesn't mean you should rush headfirst into any old Japanese stock on the hopes of a nationwide surge; as with all investing, picking the best stocks is the way to go. The country's top exporters have seen their stock rise and fall with the yen's volatility, but leading manufacturers such as Kubota (NASDAQOTH: KUBTY  ) and Komatsu (NASDAQOTH: KMTUY  ) are poised to ride a weaker yen higher to better compete against foreign rivals.

• [By Dan Carroll]

  Chinese manufacturing and materials stocks may not be the only picks in trouble, however. Leading international manufacturers could see demand in the world's second-largest economy, cutting into lofty growth expectations that relied upon China's surge to make up for weakness elsewhere around the globe. Japanese industrial power Komatsu (NASDAQOTH: KMTUY  ) , the second-largest industrial machinery manufacturer in the world, is betting on�growing Chinese demand this fiscal year, in combination with the weak yen, to fuel growth.

Best Promising Companies To Own In Right Now: Myriad Genetics Inc (MYGN)

Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests. It performs all of its molecular diagnostic testing and analysis in its own reference laboratories. These technologies include the cornerstone technologies of biomarker discovery, high-throughput deoxyribo nucleuc acid (DNA) sequencing, ribo nucleic acid (RNA) expression and multiplex protein analysis. The Company uses this information to guide the development of new molecular diagnostic tests that are designed to assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to drug therapy and guide a patient's dosing to ensure optimal treatment (personalized medicine), or assess a patient's risk of disease progression and disease recurrence (prognostic medicine).

As of June 30, 2012, the Company had launched nine commercial molecular diagnostic tests. The Company markets these tests through its own approximate 385-person sales force in the United States. The Company also markets its BRACAnalysis, COLARIS, and COLARIS AP tests through its own European sales force and have entered into marketing collaborations with other organizations in selected Latin American, European and Asian countries. The Company also generates revenue by providing companion diagnostic services to the pharmaceutical, and biotechnology industries and medical research institutions utilizing its multiplexed immunoassay technology.

Molecular Diagnostic Tests

The Company's molecular diagnostic tests are designed to analyze genes, their mutations, expression levels and proteins to assess an individual's risk for developing disease later in life, determine a patient's likelihood of responding to a particular drug, assess a patient's risk of disease progression and disease recurrence and measure a patient's exposure to drug therapy to ensu! re optimal dosing and reduced drug toxicity. The Company's BRACAnalysis test is a analysis of the BRCA1 and BRCA2 genes for assessing a woman's risk of developing hereditary breast and ovarian cancer. BRACAnalysis accounted for 81.7% of the Company's total revenue during the fiscal year ended June 30, 2012. Its The Company's COLARIS test is an analysis of the MLH1, MSH2, MSH6 and PMS2 genes for assessing a person's risk of developing colorectal cancer or uterine cancer.

The Company's COLARIS AP test detects mutations in the APC and MYH genes, which cause a colon polyp-forming syndrome known as Familial Adenomatous Polyposis (FAP), a more common variation of the syndrome known as attenuated FAP, and the MYH-associated polyposis signature (MAP). The Company's MELARIS test analyzes mutations in the p16 gene to determine genetic susceptibility to malignant melanoma. The Company's OnDose test is a nanoparticle immunoassay that is designed to assist oncologists in optimizing 5-FU (fluorouracil) anti-cancer drug therapy in colon cancer patients on an individualized basis. The Company's PANEXIA test is a comprehensive analysis of the PALB2 and BRCA2 genes for assessing a person's risk of developing pancreatic cancer later in life. The Company's PREZEON test is an immunohistochemistry test that analyzes the PTEN gene and assesses loss of PTEN function in many cancer types.

The Company's Prolaris test is a 46-gene molecular diagnostic assay that assesses whether a patient is likely to have a slow growing, indolent form of prostate cancer that can be safely monitored through active surveillance, or a more aggressive form of the disease that would warrant aggressive intervention, such as a radical prostatectomy or radiation therapy. The Company's TheraGuide 5-FU test analyzes mutations in the DPYD gene and variations in the TYMS gene to assess patient risk of toxicity to 5-FU (fluorouracil) anti-cancer drug therapy.

Companion Diagnostic Services and Other Revenue

! Through M! yriad RBM Inc., the Company provides biomarker discovery and companion diagnostic services to the pharmaceutical, biotechnology, and medical researches industries utilizing its multiplexed immunoassay technology. The Company's technology enables the Company to screen large sets of clinical samples from both diseased and non-diseased populations against the Company's menu of biomarkers. The Company's companion diagnostic services consist of Multi-Analyte Profile (MAP), Multiplexed Immunoassay Kits and TruCulture.

The Company has compiled a library of over 550 individual human and rodent immunoassays for use in its multi-analyte profile (MAP) testing services. The Company has also developed RodentMAP, a panel for use in pre-clinical animal studies and OncologyMAP, which measures cancer-related proteins to assists researchers accelerate the pace of discovery, validation and translation of cancer biomarkers for early detection, patient stratification and therapeutic monitoring. The Company has developed multiplexed immunoassay kits that enable its customers to leverage its technology services with their in-house capabilities. The Company's internally developed multiplexed immunoassay kits include all of the components necessary for a customer to perform a test on their own Luminex instrument. TruCulture is a simple, self-contained whole blood culture that can be deployed to clinical sites around the world for acquiring cell culture data without specialized facilities or training.

Advisors' Opinion:

• [By Monica Gerson]

  Breaking news

  Loews (NYSE: L) reported a 59% rise in its third-quarter earnings. Loews posted a quarterly profit of $282 million, or $0.73 per share, versus a year-ago profit of $177 million, or $0.45 per share. To read the full news, click here. BankUnited (NYSE: BKU) announced today the commencement of an underwritten offering of 9,000,000 shares of its common stock by certain of its existing stockholders, subject to market and other conditions. To read the full news, click here. Liberty Global (NASDAQ: LBTYA) announced today an agreement to sell substantially all of its international content division Chellomedia to AMC Networks (NASDAQ: AMCX).To read the full news, click here. Myriad Genetics (NASDAQ: MYGN) today announced that validation data for the Myriad myPlan Lung Cancer test showed that it significantly predicted patients' risk of death from early-stage lung adenocarcinoma within five years of being diagnosed. To read the full news, click here.

  Posted-In: Bank of America US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

• [By Luke Jacobi]

  Myriad Genetics (NASDAQ: MYGN) rose 7.70 percent to $25.31 after the company reported that CPT code pricing error should take a 'week or two' to correct. Ladenburg Thalmann upgraded the stock from Neutral to Buy.

• [By Tim Brugger]

  In a recent U.S. Supreme Court decision, a patent claim involving Myriad Genetics' (NASDAQ: MYGN  ) complementary DNA, or cDNA, has been upheld, according to a company announcement. In addition to Myriad's patent victory, however, five of its isolated DNA-related claims were denied by the court.

• [By Jake L'Ecuyer]

  Shares of Myriad Genetics (NASDAQ: MYGN) got a boost, shooting up 10.63 percent to $30.07 after the company reported upbeat fiscal second-quarter results and lifted its revenue outlook for the year. Myriad also bought Crescendo Bioscience for $270 million.

Best Promising Companies To Own In Right Now: Portola Pharmaceuticals Inc (PTLA)

Portola Pharmaceuticals, Inc. (Portola), incorporated on September 2, 2003, is a biopharmaceutical company developing product candidates that have the potential to represent advances in the fields of thrombosis and hematology. The Company is advancing its three wholly owned programs using biomarker and genetic approaches.

Betrixaban

Portola's compound, betrixaban, is an oral, once-daily Factor Xa inhibitor being evaluated in the only biomarker-based Phase-III study for hospital to home prophylaxis of venous thromboembolism (VTE) in acute medically ill patients. Betrixaban's properties particularly suited to potentially demonstrate efficacy without increasing bleeding in this patient population.

Andexanet Alfa

Portola's second development candidate, andexanet alfa (PRT4445), has the potential to be a reversal agent to directly reverse the effects of Factor Xa inhibitors in patients who suffer a bleeding episode or who require emergency surgery. Portola has entered into clinical collaboration agreements with all of the manufacturers of direct Factor Xa inhibitors, including Bristol-Myers Squibb and Pfizer (Eliquis [apixaban]), Bayer HealthCare and Janssen Pharmaceuticals (XARELTO [rivaroxaban]), and Daiichi Sankyo (Savaysa [edoxaban]), while retaining all decision-making and commercial rights to the program.

Cerdulatinib (PRT2070) and PRT2607

Portola's third wholly owned product candidate, cerdulatinib (PRT2070), is an orally available kinase inhibitor that uniquely inhibits two validated tumor proliferation pathways - spleen tyrosine kinase (Syk) and janus kinase (JAK). It is being studied in patients with leukemias or lymphomas with a focus on genetically-defined subtypes, as well as in patients who have failed therapy due to relapse or acquired mutations. Portola's fourth program is partnered with Biogen Idec and is focused on the development of PRT2607, a selective Syk inhibitor.

Advisors' Opinion:

• [By Todd Campbell]

  That leads me to Medivation (NASDAQ: MDVN  ) , Ophthotech (NASDAQ: OPHT  ) , and Portola (NASDAQ: PTLA  ) , three companies with important therapies that may very well be destined to become top sellers.

Best Promising Companies To Own In Right Now: j2 Global Inc (JCOM)

j2 Global, Inc., incorporated on December 14, 1995, is a provider of services delivered through the Internet. The Company provides cloud services to businesses of all sizes, from individuals to enterprises. The Company operates in two segments: Business Cloud Services and Digital Media. The Company's Digital Media business segment consists of the Web properties and business operations of Ziff Davis, Inc. (Ziff Davis). The Company�� cloud services and solutions include fax, voice and unified communications, email and customer relationship management, online backup, global network and operations, and customer support services. In February 2013, it acquired IGN Entertainment, Inc. On November 9, 2012, the Company acquired Ziff Davis. Effective March 18, 2013, it acquired MetroFax Inc. In April 2013, the Company acquired Backup Connect BV.

Business Cloud Services

The Company's eFax and MyFax online fax services enable users to receive faxes into their email inboxes and to send faxes via the Internet. eVoice and Onebox provides the Company's customers a virtual phone system with various available enhancements. The Company's FuseMail service provides the Company's customers email, archival and perimeter protection solutions, while Campaigner provides its customers email marketing solutions. KeepItSafe enables the Company's customers to securely backup their data and dispose of tape or other physical systems. The Company's CampaignerCRM business provides customer relationship management solutions designed to increase the Company's customers' sales and increase efficiency. The Company also generates Business Cloud Services revenues from patent licensing and sales and advertising. The Company�� Business Cloud Services and solutions are of two types: direct inward-dial number (DID) -based, which are services provided in whole or in part through a telephone number and non-DID-based, which are its other cloud services for business. As of December 31, 2012, the Company had DIDs issued! to approximately 2.1 million paying subscribers.

The Company's services allow individuals to receive and send faxes as email attachments. In addition to eFax , the Company offers online fax services under a variety of alternative brands, including MyFax , eFax Plus , eFax Pro, eFax Corporate and eFax Developer . eVoice is a virtual phone system that provides small and medium-sized businesses on-demand voice communications services, featuring a toll-free or local company DID, auto-attendant and menu tree. With these services, a subscriber can assign departmental and individual extensions that can connect to multiple United States or Canadian DIDs, including land-line and mobile phones and Internet protocol (IP) networks. These services also include advanced integrated voicemail for each extension, unifying mobile, office and other separate voicemail services and improving efficiency by delivering voicemails in both native audio format and as transcribed text. Onebox is a unified communications suite. It combines the features of many of the Company's other branded services, plus added functionality, to provide a virtual office. Onebox includes a virtual phone system, hosted email, online fax, audio conferencing and Web conferencing.

FuseMail offers hosted email, email encryption and email archival services to businesses. These solutions are hosted offsite and seamlessly integrated into a customer's existing email system. The services include hosted email, VirusSMART virus scanning, CypherSMART encryption services, SpamSMART SPAM filtering and VaultSMART / PolicySMART archiving, which delivers a secure, scalable email archiving and customizable compliance tool to correspond with a company's retention policy. Campaigner is an email marketing service that enables businesses to easily create and send personalized one-to-one email communications to subscribers and customers to build better relationships. Campaigner also helps businesses increase the size of their mailing lists, compl! y with em! ail regulations like CAN-SPAM and get more emails to more inboxes. CampaignerCRM is a cloud-based CRM solution specifically designed to help small/medium-sized businesses close more deals, reduce the sales cycle and sell larger deals. CampaignerCRM has a sales checklist capability that gives sales representatives a step-by-step plan to closing a deal. With CampaignerCRM's Social CRM capabilities, companies can seamlessly integrate a customer's latest information from Twitter, LinkedIn, and Facebook directly into their Contact profile. KeepItSafe provides managed and monitored online backup solutions for businesses, using its ISO-certified platform.

The Company's Business Cloud Services business operates multiple physical Points of Presence (POPs) worldwide, a central data center in Los Angeles and several remote disaster recovery facilities. The Company connects its POPs to its central data centers through redundant, and often times diverse, Virtual Private Networks (VPNs) using the Internet. The Company's network is designed to deliver value-added user applications, customer support and billing services for the Company's customers anywhere in the world and a local presence for its DID-based service customers from thousands of cities in 49 countries on six continents. The Company offers DIDs covering all major metropolitan areas in the United States, United Kingdom and Canada, and such other major cities as Berlin, Hong Kong, Madrid, Manila, Mexico City, Milan, Paris, Rome, Singapore, Sydney, Taipei, Tokyo and Zurich. The Company has customers located throughout the world.

The Company's Business Cloud Services customer service organization supports the Company's cloud services customers through a combination of online self-help, email communications, interactive chat sessions and telephone calls. The Company's Internet-based online self-help tools enable customers to resolve simple issues on their own, eliminating the need to speak or write to the Company's customer service re! presentat! ives. The Company's Business Cloud Services segment customer service organization provides email support seven days per week, 24 hours per day to all subscribers. Paying subscribers have access to live-operator telephone support seven days per week, 24 hours per day. Dedicated telephone support is provided for corporate customers 24 hours per day, seven days per week. Live sales and customer support services are available in nine languages, including English, Spanish, Dutch, German, French and Cantonese.

Digital Media

The Ziff Davis portfolio of Web properties, including PCMag.com, ExtremeTech.com, Geek.com, ComputerShopper.com, LogicBuy.com and Toolbox.com features reviews of technology products, technology-oriented news and commentary, professional networking tools for IT professionals and online deals and discounts for consumers. The Company generates Digital Media revenues from the sale of display advertising targeted to in-market technology buyers and from the sale of customer leads to online merchants and business-to-business leads to IT vendors. During the year ended December 31, 2012, Digital Media Web properties attracted 345 million visits and 1.1 billion page views.

PCMag is a trusted online resource for laboratory-based product reviews, technology news and buying guides. Toolbox.com is a network of online communities that allows experienced technology professionals to share collective knowledge and collaborate to resolve problems more efficiently. Toolbox.com includes professional networking tools, blogs, collaboration tools and reference guides. Geek.com is an online technology resource and community for technology enthusiasts and professionals. Its gaming site includes IGN.com and men's lifestyle site includes AskMen.com.

The Company competes with Google AdSense, DoubleClick Ad Exchange, AOL's Ad.com and Microsoft Media Network.

Advisors' Opinion:

• [By Roberto Pedone]

  Another potential earnings short-squeeze trade idea is cloud services player J2 Global (JCOM), which is set to release its numbers on Tuesday after the market close. Wall Street analysts, on average, expect J2 Global to report revenue $130.43 million on earnings of 71cents per share.

  The current short interest as a percentage of the float for J2 Global is extremely high at 20.6%. That means that out of the 43.70 million shares in the tradable float, 9.01 million shares are sold short by the bears. If the bulls get the earnings news they're looking for, then shares of JCOM could easily explode higher post-earnings.

  From a technical perspective, JCOM is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strong for the last six months, with shares moving higher from its low of $38.07 to its recent high of $56.24 a share. During that uptrend, shares of JCOM have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of JCOM within range of triggering a major breakout trade post-earnings.

  If you're in the bull camp on JCOM, then I would wait until after its report and look for long-biased trades if this stock manages to break out above its 52-week high at $56.42 a share (or Tuesday's intraday high if higher) on high volume. Look for volume on that move that hits near or above its three-month average action of 292,457 shares. If that breakout hits, then JCOM will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $65 to $75 a share.

  I would simply avoid JCOM or look for short-biased trades if after earnings it fails to trigger that breakout, and then drops below some key near-term support levels at $54 to $53 a share with high volume. If we get that move, then JCOM will set up to re-test or possibly take out its ne

• [By Rich Smith]

  j2 Global (NASDAQ: JCOM  ) just keeps on growing -- by acquisition.

  In its third corporate purchase in the past three months, j2 announced this morning that it has acquired Netherlands-based Backup Connect BV, a provider of online data backup services.

• [By Dave and Donald Moenning]

  Internet Software & Services has been the place to be in 2013. In addition to Shutterstock (SSTK), just take a look at these constituents of this red-hot sub-industry: Pandora Media (P), Facebook (FB), j2 Global (JCOM), Yelp (YELP), CoStar Group (CSGP),LinkedIn (LNKD), etc. The list of superb stocks in the Internet Software & Services space goes on and on. Focusing on stocks in the top-performing sub-industries usually helps bullish trades, so today, let's take a closer look at Shutterstock Inc for a short-term long trade.

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on j2 Global (Nasdaq: JCOM  ) , whose recent revenue and earnings are plotted below.

Best Promising Companies To Own In Right Now: Cray Inc(CRAY)

Cray Inc. engages in the design, development, manufacture, marketing, and service of high-performance computing (HPC) systems, known as supercomputers. Its product line includes Cray XE6 system, a massively parallel processing system; Cray XE6m supercomputer that incorporates its Cray Gemini network; Cray XMT supercomputer, a scalable massively multithreaded platform with a shared memory architecture that is suited for tasks, such as pattern matching, complex searches, scenario development, behavioral prediction, anomaly identification, and graph analysis; and Cray CX1 and CX1000 systems that are purpose-built for laboratories and university departments. The company?s products under development comprise Cray XE6 System enhancements; and next generation Cray XMT System. It also offers engineering services related to HPC systems and solutions, such as maintenance support services and technology-led professional services. Cray Inc. provides its products and services to gover nment agencies, academic institutions, and commercial entities in the United States, Canada, Europe, Japan, and the Asia-Pacific. The company was formerly known as Tera Computer Company and changed its name to Cray Inc. in 2000. Cray Inc. was founded in 1987 and is headquartered Seattle, Washington.

Advisors' Opinion:

• [By Jonathan Fishman]

  2. Their new product, the ClusterStor, will grow at the rate of 24%-53% a year according to the expectations of Cray (CRAY), a reseller of the ClusterStor.

• [By Alex Planes]

  What: Shares of Cray (NASDAQ: CRAY  ) have fallen by over 13% today after the company reported earnings that, in spite of narrowly beating analyst expectations, still showed a tremendous decline that may well have spooked some short-term investors.

• [By Lisa Levin]

  Cray (NASDAQ: CRAY) surged 14.40% to $31.07. The volume of Cray shares traded was 649% higher than normal. Cray affirmed its revenue outlook for 2013 and 2014.

• [By John Udovich]

  With those recent contract wins in mind, it should be noted that while Cray Inc has reported consistently rising revenues of $525.75M (2013), $421.06M (2012), $236.05M (2011) and $319.39M but more mixed net income of $32.22M (2013), $161.24M (2012), $14.33M (2011) and $15.06M (2010). Moreover and the last time Cray Inc reported earnings, shares fell 11.47% despite better-than-expected results that came with a more cautious 2014 guidance (see Is Big Data and Supercomputer Stock Cray Inc (CRAY) Still a Super Stock? SGI, IBM & HPQ for a lengthy look at what was specifically reported) while�back in February,�shares surged 39% after solid fourth-quarter results�along with�encouraging forward guidance were reported. In other words, the supercomputing business can be volatile and dependent on a few big sales.